LIFECORE BIOMEDICAL, INC. Operating Leases, Rent Expense
LIFECORE BIOMEDICAL, INC. (LFCR) reported Operating Leases, Rent Expense of $7.30 million for the 12-month period ending 2019-05-26, per its 10-Q filed 2020-04-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-04-03
- LIFECORE BIOMEDICAL, INC. operating leases, rent expense for fiscal 2017 was $5.60M, a 24.44% increase from fiscal 2016.
- LIFECORE BIOMEDICAL, INC. operating leases, rent expense for fiscal 2016 was $4.50M, a 10.00% decline from fiscal 2015.
- LIFECORE BIOMEDICAL, INC. operating leases, rent expense for fiscal 2015 was $5.00M, a 13.64% increase from fiscal 2014.
- LIFECORE BIOMEDICAL, INC. operating leases, rent expense for fiscal 2014 was $4.40M, a 8.33% decline from fiscal 2013.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2019-05-26 | $7.30M 10-Q · filed 2020-04-03 |
| 2018-05-27 | $6.10M 10-Q · filed 2020-04-03 |
| 2017-05-28 | $5.60M 10-K · filed 2019-08-01 |
| 2016-05-29 | $4.50M 10-K · filed 2018-08-09 |
| 2015-05-31 | $5.00M 10-K/A · filed 2018-03-15 |
| 2014-05-25 | $4.40M 10-K · filed 2016-08-01 |
| 2013-05-26 | $4.80M 10-K · filed 2015-07-31 |
| 2012-05-27 | $1.50M 10-K · filed 2014-08-01 |
| 2011-05-29 | $1.20M 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |